ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
Nuclear Energy Conference & Expo (NECX)
September 8–11, 2025
Atlanta, GA|Atlanta Marriott Marquis
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Aug 2025
Jan 2025
Latest Journal Issues
Nuclear Science and Engineering
September 2025
Nuclear Technology
August 2025
Fusion Science and Technology
Latest News
Chris Wagner: The role of Eden Radioisotopes in the future of nuclear medicine
Chris Wagner has more than 40 years of experience in nuclear medicine, beginning as a clinical practitioner before moving into leadership roles at companies like Mallinckrodt (now Curium) and Nordion. His knowledge of both the clinical and the manufacturing sides of nuclear medicine laid the groundwork for helping to found Eden Radioisotopes, a start-up venture that intends to make diagnostic and therapeutic raw material medical isotopes like molybdenum-99 and lutetium-177.
D. Broggio, J. Janeczko, S. Lamart, E. Blanchardon, N. Borisov, A. Molokanov, V. Yatsenko, D. Franck
Nuclear Technology | Volume 168 | Number 3 | December 2009 | Pages 824-831
MC Calculations | Special Issue on the 11th International Conference on Radiation Shielding and the 15th Topical Meeting of the Radiation Protection and Shielding Division (PART 3) / Radiation Protection | doi.org/10.13182/NT09-A9313
Articles are hosted by Taylor and Francis Online.
In vivo measurements are usually carried out under the hypothesis of a known activity distribution inside the body. The measurements and the interpretation of in vivo measurements performed with the minimum hypothesis about the activity distribution are presented and discussed. Measurements have been performed with a devoted four-germanium-detector system on a male subject presenting a 30-yr-old wound contamination by americium and plutonium isotopes. The measurements have been processed after the construction of voxelized phantoms of the measured body parts and Monte Carlo (MC) calculations of organ- and detector-specific counting efficiencies. The phantom construction and MC calculations were assisted by the OEDIPE software, and the reliability of the modeling has been controlled by a comparison of the measured and simulated efficiencies for point-source measurements and for the measurement of a Spitz anthropomorphic knee phantom. Mainly based on measurements at the knee level, the 241Am specific bone activity was (0.27 ± 23%) Bq/g. Using measurements at the thorax level, no activity could be detected in the lungs; the liver activity was between 410 and 460 Bq. The activity of the axillary, thoracic airways and trunk lymph nodes depends on the retained hypothesis, but a reasonable assessment for the axillary lymph nodes is between 100 and 350 Bq.